Rossari Biotech Ltd (ROSSARI) is currently trading at 477.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Rossari Biotech Limited is a leading manufacturer of specialty chemicals, offering sustainable chemical solutions across various industries including HPPC, TSC, and AHN. The company reported a 13% year-on-year revenue growth for Q3 FY26, driven by strong performance in international markets and steady growth across its core business segments. Rossari has recently received board approval to establish a new greenfield manufacturing facility in Saudi Arabia, aimed at enhancing its global supply chain capabilities and expanding its international footprint. Despite ongoing investments and capacity expansion efforts, Rossari maintains a solid financial structure with healthy liquidity, facilitating continued strategic growth initiatives. The company's focus on R&D and innovation is evident in the introduction of new environmentally benign chemical solutions and strategic acquisitions to enhance its product portfolio.

Over the past 52 weeks, Rossari Biotech Ltd has traded between a low of ₹474.00 and a high of ₹767.55. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Rossari Biotech Ltd has a market capitalization of approximately 2,688.31. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Rossari Biotech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.23 and operates in the Chemicals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 2,688.31 Cr, Rossari Biotech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Rossari Biotech Ltd operates in the Chemicals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Rossari Biotech Ltd is 19.23. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.